Providing Expert Treatment for all Urologic and Genitourinary Cancers
The doctors of the Stanford Urologic Cancer Program are dedicated to preserving quality of life and providing exceptional care through customized treatment plans for each patient. The program focuses on the investigation and management of cancers of the prostate, bladder, kidney, testis, and genitalia. Emphasis is placed on finding cancer treatments that take a multi-specialty approach to offer the greatest efficacy with the fewest complications.
Care and Treatment of Bladder, Kidney, Prostate, Urethra, and Testicular Cancers
Treatment at Stanford
The doctors of the Stanford Urologic Cancer Program are dedicated to preserving quality of life and providing exceptional care through customized treatment plans for each patient. Advanced treatments and technologies include:
State-of-the-art surgical techniques, including minimally invasive and robotic surgery
Immunotherapies for castration-resistant prostate cancer and high dose interleukin-2 (IL-2) for advanced kidney cancer
Advanced imaging capabilities for detection of early and advanced disease
MRI-ultrasound fusion technology for targeted prostate biopsy to quickly and accurately target suspicious tissues
Clinical trials with the latest investigational therapies and combination treatments
This technique uses extreme cold to destroy a tumor and is performed under local anesthesia as an outpatient procedure.
A procedure that involves killing the cancer by freezing the cells using extremely cold temperatures with a small metal tool placed in the tumor. Liquid nitrogen is the most common type and is sprayed on or applied with a cotton applicator to freeze growths which then shrink and fall off.
Immunotherapy (also called biological therapy, biological response modifier therapy, or biotherapy) is designed to boost the body's immune system in order to fight cancer. The cells, antibodies, and organs of the immune system work to protect and defend the body against foreign invaders, such as bacteria or viruses. Doctors and researchers have found that the immune system might also be able to both determine the difference between healthy cells and cancer cells in the body, and to eliminate the cancer cells.
An advanced type of radiation technology that manipulates beams of radiation to conform to the shape of a tumor.
Laparoscopic radical prostatectomy
A less-invasive type of radical prostatectomy in which the prostate gland is removed through small incisions using a laparoscope (a long, flexible lighted tube with a video camera attached) and special long, thin surgical tools. This type of procedure is commonly performed by a surgeon using a robot to precisely maneuver surgical tools (robotic laparoscopic radical prostatectomy).
Minimally invasive robotic surgery
The use of robotic systems to aid in surgical procedures. Robotic surgery helps to overcome limitations of minimally-invasive surgery, and broadens additional surgical capabilities.
The use of high-energy radiation to kill or shrink cancer cells, tumors, and non-cancerous diseases.
An open-surgery procedure in which the entire prostate gland and some tissue around it are removed. This surgery involves an incision in either the abdomen or the area behind the scrotum. Doctors at Stanford perform nerve-sparing prostatectomies, which maintains sexual function.
Targeted therapies can target cancerous cells without affecting healthy tissue, unlike radiation and chemotherapy treatments.
Transurethral resection of the prostate (TURP)
Surgery to remove part of the prostate gland that surrounds the urethra by using a small tool that is placed inside the prostate through the urethra at the tip of the penis. There is no incision with this method. TURP is used as a palliative procedure (to relieve symptoms), not as a procedure to cure the cancer.
In recognition of National Prostate Cancer Awareness Month, Stanford experts answer common questions about diagnosis and treatment of prostate cancer.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Maps, directions, parking, public transit options, and contact information
Other patient resources
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
Fax a referral form with supporting documentation to 650-320-9443.
Please note, though this form is from Stanford Health Care, it is also used for all Cancer Center referrals.
Track your patients' progress and communicate with Stanford providers securely online.